|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||51.62 - 53.16|
|52-week range||41.30 - 66.28|
|Beta (5Y monthly)||0.31|
|PE ratio (TTM)||N/A|
|Earnings date||04 Aug 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||63.27|
The consensus price target hints at a 28.3% upside potential for Galapagos NV (GLPG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Here is how Galapagos NV (GLPG) and Patterson Cos. (PDCO) have performed compared to their sector so far this year.
Here is how Galapagos NV (GLPG) and Halozyme Therapeutics (HALO) have performed compared to their sector so far this year.